巨子生物2024半年度业绩会

Company and Industry Summary Company Overview - The company reported a research and development expenditure of 49 million, which accounts for 1.9% of its revenue as of the reporting period [1] - As of the end of the reporting period, the company has obtained a total of 133 patents, including 40 new patents added during the reporting period [1] - The company has received recognition for three patents, which were awarded the PCQ International Invention Award [1]